Back
Intellia Therapeutics Stock Predictions
Sponsored
NTLA
Sponsored
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
14
NTLA
Intellia Therapeutics
Last Price:
$9.50
Seasonality Move:
-6.53%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]Intellia Therapeutics Stock Forecast
-
Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 42.6% based on the past 8 years of stock performance.
-
Intellia Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Intellia Therapeutics Stock Undervalued?The current Intellia Therapeutics [NTLA] share price is $9.50. The Score for NTLA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 42.6% based on the past 8 years of stock performance.
Intellia Therapeutics Stock Rating
Sell
14
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics overpriced?
-
Intellia Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Intellia Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
34.87
52-Week Low:
9.25
Prediction Charts
Market Cap:
967.6M
Price in USD:
9.50
Volume:
3.3M
Beta:
2.06
Technical Analysis
SMA50:
13.42
SMA100:
16.60
SMA200:
20.23
52-Wk Change:
-63.09%
Stock Predictions
-
Is Intellia Therapeutics stock public?Yes, Intellia Therapeutics is a publicly traded company.
-
What is the Intellia Therapeutics stock quote today?The Intellia Therapeutics stock price is 9.50 USD today.
-
How to buy Intellia Therapeutics stock online?You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-27 | 11.99 | 11.97 | 12.30 | 11.69 |
Dec-30 | 11.80 | 11.41 | 11.85 | 11.35 |
Dec-31 | 11.54 | 11.66 | 11.82 | 11.34 |
Jan-2 | 11.88 | 12.22 | 12.27 | 11.71 |
Jan-3 | 12.22 | 12.13 | 12.53 | 11.94 |
Jan-6 | 12.19 | 12.80 | 13.07 | 12.13 |
Jan-7 | 12.80 | 12.47 | 13.34 | 12.46 |
Jan-8 | 12.04 | 12.02 | 12.25 | 11.83 |
Jan-10 | 11.24 | 10.20 | 11.43 | 9.93 |
Jan-13 | 10.11 | 10.05 | 10.19 | 9.65 |
Jan-14 | 10.11 | 9.74 | 10.39 | 9.59 |
Jan-15 | 10.24 | 9.71 | 10.31 | 9.63 |
Jan-16 | 9.76 | 9.42 | 9.91 | 9.25 |
Jan-17 | 9.48 | 9.50 | 9.69 | 9.32 |
Intellia Therapeutics Earnings
Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics Forecast Revenue Growth
Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.41 per share.
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.